Citation: | Song Wei, Sun Liying, Zhu Zhijun, et al. Effect of liver transplantation on intestinal microflora in children with biliary atresia[J]. ORGAN TRANSPLANTATION, 2021, 12(6): 692-699. doi: 10.3969/j.issn.1674-7445.2021.06.008 |
[1] |
殷润开, 赵瑞芹, 付海燕, 等. 肝功能相关指标诊断婴儿胆道闭锁的价值[J]. 实用医学杂志, 2021, 37(12): 1607-1612. DOI: 10.3969/j.issn.1006-5725.2021.12.019.
YIN RK, ZHAO RQ, FU HY, et al. Value of liver function index in the diagnosis of biliary atresia in infants[J]. J Pract Med, 2021, 37(12): 1607-1612. DOI: 10.3969/j.issn.1006-5725.2021.12.019.
|
[2] |
SOKOL RJ, SHEPHERD RW, SUPERINA R, et al. Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop[J]. Hepatology, 2007, 46(2): 566-581. DOI: 10.1002/hep.21790.
|
[3] |
SIDDIQUI AI, AHMAD T. Biliary atresia[M]. Treasure Island (FL): StatPearls, 2021.
|
[4] |
KASAHARA M, UMESHITA K, SAKAMOTO S, et al. Liver transplantation for biliary atresia: a systematic review[J]. Pediatr Surg Int, 2017, 33(12): 1289-1295. DOI: 10.1007/s00383-017-4173-5.
|
[5] |
WEI Y, LI Y, YAN L, et al. Alterations of gut microbiome in autoimmune hepatitis[J]. Gut, 2020, 69(3): 569-577. DOI: 10.1136/gutjnl-2018-317836.
|
[6] |
HU H, LIN A, KONG M, et al. Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives[J]. J Gastroenterol, 2020, 55(2): 142-158. DOI: 10.1007/s00535-019-01649-8.
|
[7] |
CASSARD AM, CIOCAN D. Microbiota, a key player in alcoholic liver disease[J]. Clin Mol Hepatol, 2018, 24(2): 100-107. DOI: 10.3350/cmh.2017.0067.
|
[8] |
MILOSEVIC I, VUJOVIC A, BARAC A, et al. Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature[J]. Int J Mol Sci, 2019, 20(2): 395. DOI: 10.3390/ijms20020395.
|
[9] |
MOHAJERI MH, BRUMMER RJM, RASTALL RA, et al. The role of the microbiome for human health: from basic science to clinical applications[J]. Eur J Nutr, 2018, 57(Suppl 1): 1-14. DOI: 10.1007/s00394-018-1703-4.
|
[10] |
XING HC, LI LJ, XU KJ, et al. Protective role of supplement with foreign bifidobacterium and lactobacillus in experimental hepatic ischemia-reperfusion injury[J]. J Gastroenterol Hepatol, 2006, 21(4): 647-656. DOI: 10.1111/j.1440-1746.2006.04306.x.
|
[11] |
ZHU B, WANG X, LI L. Human gut microbiome: the second genome of human body[J]. Protein Cell, 2010, 1(8): 718-725. DOI: 10.1007/s13238-010-0093-z.
|
[12] |
WANG J, QIAN T, JIANG J, et al. Gut microbial profile in biliary atresia: a case-control study[J]. J Gastroenterol Hepatol, 2020, 35(2): 334-342. DOI: 10.1111/jgh.14777.
|
[13] |
ASAI A, MIETHKE A, BEZERRA JA. Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes[J]. Nat Rev Gastroenterol Hepatol, 2015, 12(6): 342-352. DOI: 10.1038/nrgastro.2015.74.
|
[14] |
ZENG Y, CHEN S, FU Y, et al. Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma[J]. J Viral Hepat, 2020, 27(2): 143-155. DOI: 10.1111/jvh.13216.
|
[15] |
LV LX, FANG DQ, SHI D, et al. Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis[J]. Environ Microbiol, 2016, 18(7): 2272-2286. DOI: 10.1111/1462-2920.13401.
|
[16] |
WENG MT, CHIU YT, WEI PY, et al. Microbiota and gastrointestinal cancer[J]. J Formos Med Assoc, 2019, 118(Suppl 1): S32-S41. DOI: 10.1016/j.jfma.2019.01.002.
|
[17] |
TANG R, WEI Y, LI Y, et al. Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy[J]. Gut, 2018, 67(3): 534-541. DOI: 10.1136/gutjnl-2016-313332.
|
[18] |
ABE K, FUJITA M, HAYASHI M, et al. Gut and oral microbiota in autoimmune liver disease[J]. Fukushima J Med Sci, 2020, 65(3): 71-75. DOI: 10.5387/fms.2019-21.
|
[19] |
TRIPATHI A, DEBELIUS J, BRENNER DA, et al. The gut-liver axis and the intersection with the microbiome[J]. Nat Rev Gastroenterol Hepatol, 2018, 15(7): 397-411. DOI: 10.1038/s41575-018-0011-z.
|
[20] |
ISAACS-TEN A, ECHEANDIA M, MORENO-GONZALEZ M, et al. Intestinal microbiome-macrophage crosstalk contributes to cholestatic liver disease by promoting intestinal permeability in mice[J]. Hepatology, 2020, 72(6): 2090-2108. DOI: 10.1002/hep.31228.
|
[21] |
YANG X, LU D, ZHUO J, et al. The gut-liver axis in immune remodeling: new insight into liver diseases[J]. Int J Biol Sci, 2020, 16(13): 2357-2366. DOI: 10.7150/ijbs.46405.
|
[22] |
ISLAM KB, FUKIYA S, HAGIO M, et al. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats[J]. Gastroenterology, 2011, 141(5): 1773-1781. DOI: 10.1053/j.gastro.2011.07.046.
|
[23] |
LONG SL, GAHAN CGM, JOYCE SA. Interactions between gut bacteria and bile in health and disease[J]. Mol Aspects Med, 2017, 56: 54-65. DOI: 10.1016/j.mam.2017.06.002.
|
[24] |
BAJAJ JS, FAGAN A, SIKAROODI M, et al. Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis[J]. Liver Transpl, 2017, 23(7): 907-914. DOI: 10.1002/lt.24754.
|
[25] |
BAJAJ JS, KAKIYAMA G, COX IJ, et al. Alterations in gut microbial function following liver transplant[J]. Liver Transpl, 2018, 24(6): 752-761. DOI: 10.1002/lt.25046.
|
[26] |
NORVELL JP. Spotlight on impactful research: impact of liver transplantation on gut microbiota and cognitive function[J]. Clin Liver Dis (Hoboken), 2019, 13(3): 72-73. DOI: 10.1002/cld.746.
|
[27] |
PILLAI AA, LEVITSKY J. Overview of immunosuppression in liver transplantation[J]. World J Gastroenterol, 2009, 15(34): 4225-4233. DOI: 10.3748/wjg.15.4225.
|
[28] |
SUN LY, YANG YS, QU W, et al. Gut microbiota of liver transplantation recipients[J]. Sci Rep, 2017, 7(1): 3762. DOI: 10.1038/s41598-017-03476-4.
|
[29] |
ZHANG J, REN FG, LIU P, et al. Characteristics of fecal microbial communities in patients with non-anastomotic biliary strictures after liver transplantation[J]. World J Gastroenterol, 2017, 23(46): 8217-8226. DOI: 10.3748/wjg.v23.i46.8217.
|
[30] |
HOLOTA Y, DOVBYNCHUK T, KAJI I, et al. The long-term consequences of antibiotic therapy: role of colonic short-chain fatty acids (SCFA) system and intestinal barrier integrity[J]. PLoS One, 2019, 14(8): e0220642. DOI: 10.1371/journal.pone.0220642.
|
[31] |
AGUS A, CLÉMENT K, SOKOL H. Gut microbiota-derived metabolites as central regulators in metabolic disorders[J]. Gut, 2021, 70(6): 1174-1182. DOI: 10.1136/gutjnl-2020-323071.
|